Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yungshin Global Holding Corp. (3705:TWSE), powered by AI.
Yungshin Global Holding Corp. is currently trading at $57.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Yungshin Global Holding Corp. on Alpha Lenz.
View Yungshin Global Holding Corp.'s valuation metrics on Alpha Lenz.
“Yungshin Global Holding Corp.'s ROE is 10.9%. Explore profitability and growth together.”
Ask for details →Yungshin Global Holding Corp. is a major player in the pharmaceutical industry, primarily engaged in the development, production, and distribution of pharmaceutical products. The company’s product line encompasses a wide array of medications, including both over-the-counter products and prescription drugs. Yungshin's reach extends beyond pharmaceuticals, as it diversifies into the production of veterinary medicines and other healthcare-related products. Its operations significantly impact the healthcare and biotechnology sectors, contributing to global health by ensuring the availability of essential medicines. With a robust infrastructure for research and development, Yungshin Global Holding Corp. remains at the forefront of pharmaceutical innovation, striving to address evolving healthcare needs on a global scale. As a pivotal entity in its sector, the company plays a crucial role in market dynamics by adjusting to regulatory changes and advancing medical science through innovative solutions.
“Yungshin Global Holding Corp.'s ROE is 10.9%. Explore profitability and growth together.”
Ask for details →Yungshin Global Holding Corp. (ticker: 3705) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 57.2 with a P/E ratio of -x and P/B of -x.
ROE is 10.92% and operating margin is 15.77%. Annual revenue is $8.4B.